Health Care & Life Sciences » Pharmaceuticals | Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.16
Market Cap
CNY6.68 B
Shares Outstanding
595.14 M
Public Float
332.93 M

Profile

Address
North End of Yinchuan Avenue
Shijiazhuang Hebei 050800
China
Employees -
Website http://www.heparin.cn
Updated 07/08/2019
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of heparin active pharmaceutical ingredient (API) and heparin preparations. Its products include heparin raw materials, heparin sodium injection, enoxaparin sodium API, heparin sodium raw materials, low molecular weight heparin calcium drug, enoxaparin sodium injection, and low molecular weight heparin calcium injection. The company was founded on September 28, 2000 and is headquartered in Shijiazhuang, China.

Financials

View All
Created with Highcharts 5.0.14Hebei Changshan Biochemical Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values CNY Millions.115115134134156156175175197197140140201320142015201620172018050100150200250
Created with Highcharts 5.0.14Hebei Changshan Biochemical Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values CNY Millions.7007008078079119111 1051 1051 3991 3991 6281 6282013201420152016201720180500100015002000

Wei Qiao
Chairman-Supervisory Board
Jin Liang Wang
Member-Supervisory Board